StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Down 2.8 %
NYSE:BTX opened at $1.04 on Friday. The company has a market capitalization of $61.18 million, a PE ratio of -0.46 and a beta of 4.61. Brooklyn ImmunoTherapeutics has a 52-week low of $0.17 and a 52-week high of $10.10. The stock has a fifty day simple moving average of $1.57 and a 200-day simple moving average of $1.87.
Brooklyn ImmunoTherapeutics Company Profile
Read More
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Want to Profit on the Downtrend? Downtrends, Explained.
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- What is Put Option Volume?
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- The 3 Best Blue-Chip Stocks to Buy Now
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.